Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. Life Science Investing
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies Life Science Investing
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy Life Science Investing
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes Life Science Investing
Innovotech Inc. Announces CFO Transition and Reports 2026 Annual General Meeting Result Life Science Investing
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 Life Science Investing
Enveric Biosciences Announces Participation in 2026 BIO International Convention Life Science Investing
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale Life Science Investing
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial Life Science Investing
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata Life Science Investing
NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes Life Science Investing
